Use of 11α-deuterium labeled cortisol as a tracer for assessing reduced 11β-HSD2 activity in vivo following glycyrrhetinic acid ingestion in a human subject
Use of 11α-deuterium labeled cortisol as a tracer for assessing reduced 11β-HSD2 activity in vivo following glycyrrhetinic acid ingestion in a human subject
复制标题
DOI:
10.1016/j.steroids.2004.10.006
复制
发表时间:
2005-02-01
期刊:
影响因子:
2.7
通讯作者:
Furuta, T
中科院分区:
文献类型:
--
作者:
Kasuya, Y;Yokokawa, A;Furuta, T
This study describes an oral administration of 5 mg of [1,2,4,19-C-13(4),11alpha-H-2]cortisol (cortisol-C-13(4),H-2(1)) to a human subject performed on two separate occasions, one with cortisol-C-13(4),H-2(1) alone and the other with Cortisol-C-13(4),H-2(1) plus 130 mg per day of glycyrrhetinic acid for 6 days. The stable isotope methodology employed allowed for the evaluation of the individual in vivo activities of the two isozymes of 11beta-hydroxysteroid dehydrogenase (11beta-HSD), 11beta-HSD1 and 11beta-HSD2, and to demonstrate the sensitivity of changes in cortisol elimination half-life for detecting inhibition of 11beta-HSD2 activity induced with glycyrrhetinic acid. The kinetic analysis associated with the loss of 11alpha-H-2 during the conversion of Cortisol-C-13(4),H-2(1) to cortisone-C-13(4) by 11beta-HSD2 clearly indicated reduced 11beta-HSD2 activity with glycyrrhetinic acid ingestion, as observed by an increase in the elimination half-life of cortisol-C-13(4),H-2(1). The elimination half-life of cortisol-C-13(4),H-2(1) provided sensitive in vivo measures of 11beta-HSD2 activity and was more sensitive for detecting changes in renal 11beta-HSD2 activity than the measurement of the urinary ratio of free cortisol and free cortisone (UFF/UFE). The H-2-labeling in the 11alpha-position of cortisol served as an appropriate tracer for assessing the reduced 11beta-HSD2 activity in vivo induced by glycyrrhetinic acid. (C) 2004 Elsevier Inc. All rights reserved.